Inside informationEnglish
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 15/12/2025, 18:39
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 115033_20251215